Future studies are needed to thoroughly investigate this hypothesis as well as evaluate the factors secreted by obASCs that upregulate SERPINE1 to develop therapeutic strategies to block this obesity-mediated promotion of metastatic disease. This evidence concerns the gene SERPINE1 and obesity due to melanocortin 4 receptor deficiency.